Skip to content

aktsiaselts Surgitech

Registry code (registrikood) 10453754Public limited company (Aktsiaselts)VAT EE100533817Activity (EMTAK 4646): Ravimite ja meditsiinikaupade hulgimüükActive

Tallinn, Harju County · Financial data: annual reports up to 2025; tax data up to 2026 Q2

Revenue (2025)
€18.6M
▲ 0.5% vs 2024
Profit before tax (2025)
€1.6M
Employees, FTE (2025)
32
State taxes paid, last 4 quarters
€5.1M

Revenue, profit and employees, 2019–2025

€14.2M2019€14.4M2020€18.9M2021€18.4M2022€17.5M2023€18.5M2024€18.6M2025
YearRevenue (müügitulu)Operating profit (ärikasum)Net profitEquity (omakapital)Employees, FTE
2019€14,163,248€730,536€611,766€2,506,88230
2020€14,364,177€1,168,193€1,064,748€3,021,63030
2021€18,912,848€2,035,786€1,775,986€3,557,61632
2022€18,449,236€1,740,802€1,512,586€3,880,20232
2023€17,548,871€1,463,682€1,207,580€3,637,78234
2024€18,540,342€1,697,511€1,412,879€3,380,66134
2025€18,636,452€1,618,283€1,384,931€3,758,42732

Balance sheet summary

YearCashTotal assetsCurrent liabilitiesNon-current liabilitiesEquity
2019€1,413,238€6,413,670€3,282,156€624,632€2,506,882
2020€2,532,591€7,760,621€4,237,372€501,619€3,021,630
2021€3,100,117€8,934,654€4,699,698€677,340€3,557,616
2022€2,050,028€8,519,615€3,836,578€802,835€3,880,202
2023€1,776,848€8,812,611€4,540,031€634,798€3,637,782
2024€1,445,762€7,809,918€4,213,432€215,825€3,380,661
2025€1,001,272€8,096,243€4,277,136€60,680€3,758,427

Calculated ratios

Net profit margin = net profit ÷ revenue. Equity ratio = equity ÷ total assets. Seedata sources & methodology for how each figure is derived.

Quarterly tax and turnover data (EMTA)

QuarterState taxes paidWage taxesTurnoverEmployees
2022 Q1€955,302€187,793€7,801,13329
2022 Q2€918,863€169,399€9,131,39330
2022 Q3€964,187€172,576€7,671,42530
2022 Q4€1,011,956€168,931€8,074,98531
2023 Q1€1,077,611€184,777€7,683,74930
2023 Q2€1,083,611€185,395€7,719,96130
2023 Q3€917,582€190,845€6,883,57527
2023 Q4€1,153,789€174,572€8,072,10529
2024 Q1€1,226,339€226,959€8,373,47130
2024 Q2€1,253,591€195,189€8,068,92332
2024 Q3€1,067,126€216,203€7,408,70230
2024 Q4€1,177,376€207,468€7,412,77428
2025 Q1€1,274,668€215,230€8,181,29331
2025 Q2€1,220,886€222,281€7,932,83532
2025 Q3€1,185,375€247,386€7,302,46334
2025 Q4€1,315,694€225,613€8,170,65835
2026 Q1€1,326,423€247,030€8,981,26936
2026 Q2€1,226,842€206,495€7,803,86937

Source: EMTA quarterly published data, as of 10 July 2026. Covers state taxes and wage taxes actually paid and turnover and employee counts as declared by the company, not the annual report figures above.

About this data

In the 2025 financial year (period 1 January 2025–31 December 2025), aktsiaselts Surgitech reported revenue of €18,636,452.

The company closed the 2025 financial year with a net profit of €1,384,931.

Revenue increased by 0.5% from €18,540,342 in 2024 to €18,636,452 in 2025.

Revenue grew at a compound annual rate of 4.7% between 2019 and 2025.

Equity accounted for 46.4% of total assets of €8,096,243 at the end of the 2025 reporting period.

With 32 full-time-equivalent employees in 2025, revenue per employee was €582,389.

Across the 4 most recent quarters declared to EMTA, up to Q2 2026, aktsiaselts Surgitech reported €32,258,259 in turnover.

EMTA recorded 37 employees for the quarter ending Q2 2026, compared with 32 full-time-equivalent employees in the 2025 annual report.

Browse

Source

Source: Estonian e-Business Register open data (Centre of Registers and Information Systems, RIK), licence CC BY-SA 4.0, modified; Estonian Tax and Customs Board (EMTA) quarterly data. Downloaded 2026-09-22. This is not an official register extract — see ariregister.rik.ee.

Company data on this site is available under CC BY-SA 4.0.

To request a correction or the removal of this page, use the contact form. Removal requests are handled within 30 days, no justification required.